ALZN Market Cap History
Below is a table of the ALZN market cap history going back to 6/15/2021:

Date ALZN Market Cap
6/15/20211.15B
7/20/2021447.85M
9/13/2021241.55M
12/13/2021213.24M

Also see: ALZN Shares Outstanding History
and ALZN YTD Return
ALZN Historical Market Cap:
-164.15% CAGR
ALZN Historical Market Cap: +-164.15% CAGR

Mouse over chart for data details
6/15/20217/20/20219/13/202112/13/2021
Alzamend Neuro is a specialty pharmaceutical company engaged in the development and commercialization of patented intellectual property to prevent, treat and cure Alzheimer's disease ("Alzheimer's" or "AD"). Co. has licensed an immunotherapy vaccine peptide that works both as a treatment and vaccine against Alzheimer's and an ionic cocrystal of lithium to mitigate extreme agitation and forestall other deterioration as displayed by patients with up to moderate AD and possibly other neurodegenerative diseases. Co. devotes substantially all its efforts towards research and development of its Technology and raising capital. We show 4 historical shares outstanding datapoints in our ALZN shares outstanding history coverage, used to compute ALZN market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ALZN market cap history over the course of time is important for investors interested in comparing ALZN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ALZN versus a peer is one thing; comparing ALZN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ALZN can fluctuate over the course of history. With this page we aim to empower investors researching ALZN by allowing them to research the ALZN market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree ALZN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Alzamend Neuro (ALZN) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

AMAG Market Cap History
AMDA Market Cap History
AMED Market Cap History
AMEH Market Cap History
AMGN Market Cap History
AMN Market Cap History
AMPH Market Cap History
AMRX Market Cap History
AMTI Market Cap History
ANAB Market Cap History
More Healthcare companies »

 

ALZN Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.